Insider buys at Rapid Micro Biosystems signal confidence in upcoming product launches, regulatory approvals and a potential upside toward its 52‑week high.
Insider sell‑offs at Rapid Micro Biosystems signal mounting uncertainty, with CFO and CEO liquidating thousands of shares amid a negative P/E and stalled product launch. Investors face a trade‑off between niche tech potential and near‑term earnings …